Early surgery linked to better survival in muscle-invasive bladder cancer
A study suggests that undergoing surgery within 14 days significantly improves survival for patients with muscle invasive bladder cancer.
News
-
-
Researchers find bladder cancer places a heavy financial burden on patients
Bladder cancer can cause serious money problems for patients during treatment, according to a recent review.
-
Repeated urinary infections may signal bladder cancer
Having many urinary tract infections (UTIs) within six months may be a strong warning sign for bladder cancer, according to a recent study.
-
Experimental bladder cancer treatment TARA-002 shows promise in mid-stage trial
Early trial data show a 68% complete response rate for Protara Therapeutics’ TARA-002 in BCG-unresponsive non-muscle invasive bladder cancer.
-
Study identifies glycolysis genes that influence bladder cancer risk
A new study suggests that certain genes involved in how cells process sugar for energy may influence the risk of bladder cancer,
-
Combination treatment improves survival in cisplatin-eligible MIBC
Pembrolizumab and enfortumab vedotin reduce the risk of death, progression or recurrence in muscle invasive bladder cancer, Pfizer shared.
-
Experts create new recommendations for muscle-invasive bladder cancer
Combining surgery or radiation with new treatments can improve outcomes, concluded the International Bladder Cancer Group.
-
Researchers examine influence of carcinogens in bladder cancer
Scientists are developing new ways to stop carcinogens from causing bladder cancer.
-
Study shows tumor DNA guides safer bladder-sparing treatment
Nearly seven in 10 patients with bladder cancer with a complete response were alive with their bladder intact at three years.
-
Living in a disadvantaged area raises bladder cancer death risk
Where a patient lives and the resources in that neighborhood can influence the risk of dying from bladder cancer over time.